Recently, according to official news from Shaanxi Sanfu Le Technology Group, Kangyina Acquisition Company (SPAC), which was initiated and established by the group's founder Yuan Xiaofeng, announced on October 13 that it would publicly offer 6 million units at a price of US$10.00 per unit. Each unit consists of one ordinary share and one right share. Each right entitles its holder to receive two tenths (2/10) of a priced ordinary share after the company completes its initial business combination. These units are expected to start trading on the Global Market of the NASDAQ Stock Exchange on October 14 (currently postponed). The trading codes of these units, ordinary shares and rights on the NASDAQ Stock Exchange will be "TENKU", "TENK" and "TENKR" respectively. Maxim Group LLC is the sole bookrunner for this offering. It is reported that the company has granted the underwriters a 45-day option to purchase up to an additional 900,000 offering units at the initial public offering price in case of over-allotment. This offering is expected to be completed on October 18, subject to customary closing conditions. TenX Keane is a blank-check company, commonly also referred to as a Special Purpose Acquisition Company (SPAC), which aims to complete a business combination with one or more entities through mergers, equity exchanges, asset acquisitions, equity purchases, capital reorganizations, restructurings or other similar business combination methods. The sponsor of TenX Keane this time, Yuan Xiaofeng, founder of Sanfu Le Technology Group, currently serves as the chairman of Sanfu Le Group, vice president of China Reproductive Health Industry Association, specially-appointed expert of the Shaanxi Provincial Committee of the Chinese People's Political Consultative Conference, and part-time professor of Xi'an Jiaotong University. Yuan Xiaofeng has successively won the titles of Top Ten Youths of Shaanxi Province and Expert with Outstanding Contributions in Shaanxi Province. Yuan Xiaofeng founded Sanfu Le in Xianyang in 1992. The company is mainly engaged in the R&D, production and marketing of women's health products. Its products are sold well at home and abroad and are deeply loved by the majority of women. The group has 4 national high-tech enterprises, one provincial enterprise technology center, one municipal engineering technology center, a Sanqin Scholar innovation team and a scientist + engineer team. There are currently more than 100 products in 11 series including pharmaceuticals, health care products, medical devices, sanitary products, special medical foods, cosmetics, healthy clothing and more. The product sales network covers the entire country, and branches have been established in Canada, Russia, Kazakhstan, Africa and other countries and regions. The four major bases under the group, namely Xi'an Sanfu Le Times Square Headquarters Base, Yangling Sanfu Le Health Products Production Base, Zhashui Sanfu Le Functional Food Production Base and Chunhua Sanfu Le Horse Chestnut Planting Base, are all thriving. Meanwhile, Sanfu Le is the drafting unit of national reproductive health product standards, and has also entered the Class A ranks of Shaanxi Province's listed reserve enterprises. According to market news, on July 19, the signing ceremony for Sanfu Le Group's acquisition of Canada M&D Natural Health Company was held in Vancouver, Canada. Professor Yuan Xiaofeng, chairman of Shaanxi Sanfu Le Technology Group, and Dr. Peter Yang, executive director of M&D Natural Health Company, attended the signing ceremony. It is understood that Canada M&D Natural Health Company is located in Vancouver, Canada. It is a comprehensive enterprise integrating product R&D, health food production and natural food raw material manufacturing. It holds 136 Natural Product Number (NPN) certificates for natural health foods issued by Health Canada. The company has passed the GMP and FDA dual production quality management system certifications and obtained the food safety manufacturing license from Health Canada. The company has 4 independent brands, owns the fourth-generation NMN product innovation formula, has successfully developed HGH gel penetration technology, and its products have entered the markets of 30 countries and regions including South Korea, South America and the Middle East. Yuan Xiaofeng stated at the ceremony that Sanfu Le Group will be listed on the NASDAQ in the United States in the near future. Taking this opportunity, Sanfu Le will give full play to the capital and platform advantages of a listed company, attract more partners to join Sanfu Le, comprehensively enhance the company's competitiveness, and jointly build a win-win development platform. © 2021 Meishun (Hong Kong) Management Consulting Co., Ltd. and Meishun (Hangzhou) Management Consulting Co., Ltd. All rights reserved. Meishun Meiyin (Hangzhou) Consulting Management Co., Ltd. is the domestic subsidiary of Hong Kong Meishun Management Consulting Company under the same ultimate beneficial owner. Both companies share the same actual controller and are managed under the same Chinese management framework, complying with the laws of Hong Kong and mainland China.